登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Lancet，6月18日，Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-06-19

  • Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation

    Andrea Duca

    Irdi Memaj

    Federico Zanardi

    Carlo Preti

    Andrea Alesi

    Lorenzo Della Bella

    et al.

    Show all authors

    Open AccessPublished:June 18, 2020DOI:https://doi.org/10.1016/j.eclinm.2020.100419

    Abstract

    Background

    Novel Coronavirus SARS-CoV-2 pandemic is spreading around the world. At the end of February, the outburst of the pandemic has hit hard on northern Italian's hospitals. As of today, no data have been published regarding the severity of respiratory failure of patients presenting to the Emergency Departments. Moreover, the outcome the patients forced to undergo Continuous Positive Airway Pressure (CPAP) or Non-Invasive Positive Pressure Ventilation (NIPPV) due to lack of Intensive Care resources is unknown. “Papa Giovanni XXIII” hospital (HPG23) of Bergamo is one of the largest hospitals in the Country, with an Emergency Department (ED) managing over 100,000 patients per year.

    Methods

    This is a retrospective observational study based on chart review of patients presenting to the Emergency Department of HPG23 from 29/02/2020 to 10/03/2020 with a clinical condition highly suspicious for COVID-19 infection. Registration of admission rates, severity of respiratory failure (ARDS classification), need of respiratory support, SARS-CoV-2 PCR test and outcome of patients treated with a ventilatory support were registered on 10th of May 2020.

  • 原文来源：https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30163-2/fulltext
14浏览量
原文链接
相关报告

  • 《Lancet，3月6日，Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' reply》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-07
    • Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' reply Jianhui Wang Yuan Shi Published:March 06, 2020DOI:https://doi.org/10.1016/S2352-4642(20)30072-9 We thank Daniele De Luca for his reflections on our Comment.1 We agree that testing all admitted neonates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not necessary. We recommended screening all newly admitted infants at high risk of coronavirus disease 2019 (COVID-19) on the basis of their family history. Only high-risk patients should receive a nucleic acid test for SARS-CoV-2. However, all high-risk neonates should be isolated in a single room, preferably in a neonatal intensive care unit (NICU). Based on existing experience, some patients initially present with mild flu-like symptoms but rapidly develop respiratory distress and multiple organ failure. Admitting all neonates with COVID-19 to the NICU could ensure the availability of close monitoring and necessary interventions.2 However, each clinical setting should consider its bed surge capacity in case of a COVID-19 outbreak and adopt a flexible and variable approach to admitting patients.
    12浏览量
    原文链接

  • 《LANCET，5月18日，Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-05-19
    • Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases Jialin Teng † Jin Dai † Yutong Su † Zhuochao Zhou Huihui Chi Liyan Wan Published:May 18, 2020DOI:https://doi.org/10.1016/S2665-9913(20)30128-4 Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases In December, 2019, an outbreak of the novel coronavirus (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) occurred in Wuhan, China,1 and soon spread all over the world. Rapid and accurate diagnosis of SARS-CoV-2 infection is the cornerstone of all efforts to stem its advancement. Molecular detection via RT-PCR can result in falsely negative results due to the low viral loads in a sample. Serological methods are being developed and have proven to be a useful supplementary approach in confirming SARS-CoV-2 infection.2 The US Food and Drug Administration has issued numerous Emergency Use Authorisations, including serological tests; however, the potential for cross-reactivity with antibodies present in the sera of patients with other diseases remains largely unknown. Cross-reactivity of antibodies against SARS-CoV-2 with antibodies against other coronaviruses, such as SARS-CoV, has been shown.3 In addition, cross-reactivity has been observed from autoantibodies in serum samples from patients with autoimmune disease when testing for SARS-CoV,4 which shares high sequence identity with SARS-CoV-2. As such, we wanted to determine whether autoantibodies interfere with detection of SARS-CoV-2 antibodies.
    28浏览量
    原文链接